Comparison of topical 1% Clotrimazole and Sertaconazol in treatment of erythrasma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201202142581N3

Enrollment

Registered

2012-06-09

Start date

2011-04-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

erythrasma. L08.1

Interventions

Intervention 1: Control group: cream clotrimazole 1% BId for two weeks. Intervention 2: intervention group: cream sertaconazole BID for two weeks.

Treatment - Drugs

Control group: cream clotrimazole 1% BId for two weeks.

intervention group: cream sertaconazole BID for two weeks.

Eligibility

Sex/Gender

All

Age

12 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1- Documented erythrasma cases with no topical therapy in recent 30 days. 2- Documented erythrasma cases with no sensitivity to clotrimuzole or sertaconazol. Exclusion crireria: 1- Patients with treated erythrasma in recent 30 days. 2- Patients with sensitivity to clotrimazole or setaconazol. 3- Any patient with systemic disorder 4- Any patients with history of drug reaction.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Severity. Timepoint: Every 7 days. Method of measurement: History, clinical examination.	—

Secondary

Measure	Time frame
No used. Timepoint: No used. Method of measurement: No used.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026